XML 27 R20.htm IDEA: XBRL DOCUMENT
v3.25.0.1

LICENSING AGREEMENTS | 9 Months Ended
--- | ---
Sep. 30, 2024
Licensing Agreements |
LICENSING AGREEMENTS | NOTE 8. LICENSING AGREEMENTS On July 10, 2024, Akos entered into an Exclusive License Agreement (the “License Agreement”) with Aries Science and Technology, LLC, an Ohio limited liability company (“Aries”), pursuant to which Akos granted Aries a license of Akos’s patented radiation dermatitis topical product. The license allows Akos to use the patented formulation to develop pharmaceutical or non-pharmaceutical products for treating radiation dermatitis suitable for administration to humans or animals. The license is exclusive (subject to certain exceptions contained in the License Agreement), worldwide, royalty-bearing, and includes the right to sublicense. Akos is entitled to potential license payments, milestone payments and royalties based on net revenues of the Licensed Product on a licensed product-by-licensed product and country-by-country basis pursuant to the terms of the Agreement. Aries has the option during the license term, to purchase the rights to each licensed product (on a licensed product-by-licensed product basis) in the form of an exclusive (as to the applicable licensed product), fully paid, transferable right and license to the licensed product. The Company has not earned any revenue related to this agreement as of September 30, 2024. ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

X
- References No definition available. + Details
Name: | ENVB_DisclosureLicensingAgreementsAbstract
Namespace Prefix: | ENVB_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Licensing Agreements Disclosure [Text Block] + References No definition available. + Details
Name: | ENVB_LicensingAgreementsDisclosureTextBlock
Namespace Prefix: | ENVB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration